Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

There are still challenges in diagnosing and treating chronic skin diseases, but there is hope for future improvements.

The FOXN1 gene is crucial for developing immune cells and preventing immune disorders.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

Tumor immunotherapy can cause hair loss by disrupting hair follicle immunity.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

Behçet's Disease may be caused by genetic and environmental factors leading to abnormal immune responses, and stress management and new treatments could improve patient outcomes.

Erianin may effectively treat alopecia areata by targeting the immune system.

Keratinocytes help heal skin wounds by interacting with immune cells and producing substances that kill pathogens.

A specific enzyme is crucial for the bean plant's relationship with certain beneficial soil bacteria and fungi.

Mouse hair follicle stem cells can help prevent Type 1 Diabetes.

UV light helped human hair transplants survive in mice without broad immunosuppression.

The conditions alopecia areata, primary sclerosing cholangitis, and ulcerative colitis may be linked by shared autoimmune and cell death mechanisms.

New treatments for the autoimmune hair loss condition alopecia areata may include JAK inhibitors and other immunomodulators.

Bullous pemphigoid is influenced by genetic factors, immune cell dysfunction, aging, and triggers, with treatment often improving symptoms.

The review suggests that other immune cells besides CD8+ T cells may contribute to alopecia areata and that targeting regulatory cell defects could improve treatment.

Alopecia areata is caused by immune attacks on hair follicles, affecting hair growth and quality of life.

New treatments for alopecia areata, like JAK inhibitors and immunomodulators, are promising.

Hair regrowth in alopecia universalis may be possible by altering immune cells.

Hair follicles are normally protected from the immune system, but when this protection fails, it can cause hair loss in alopecia areata.

ILC1-like cells can independently cause alopecia areata.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

Alopecia areata is an autoimmune disease causing hair loss, treatable with immune-modulating drugs, and linked to genetics.

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.

taVNS reduces vitiligo symptoms in mice.

Alopecia areata is an autoimmune disease where T cells attack hair follicles.

JAK inhibitors are effective for treating moderate-to-severe alopecia areata.

Blocking JAK3 signaling can reverse hair loss from alopecia areata.

SADBE treatment led to complete hair regrowth in mice with alopecia areata by altering immune cell movement.

Specific genes influence hair and cashmere growth in Laiwu black goats.